Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
28,412,394
-
Total 13F shares
-
23,575,560
-
Share change
-
-2,280,159
-
Total reported value
-
$144,513,022
-
Put/Call ratio
-
59%
-
Price per share
-
$6.13
-
Number of holders
-
114
-
Value change
-
-$42,534,233
-
Number of buys
-
60
-
Number of sells
-
78
Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) as of Q4 2025
As of 31 Dec 2025,
Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,575,560 shares.
The largest 10 holders included
FEDERATED HERMES, INC., BlackRock, Inc., ARK Investment Management LLC, VANGUARD GROUP INC, Sumitomo Mitsui Trust Group, Inc., Amova Asset Management Americas, Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, TWO SIGMA INVESTMENTS, LP, and TWO SIGMA ADVISERS, LP.
This page lists
114
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.